Crotylbarbital

Crotylbarbital

Clinical data
ATC code	none
Identifiers
IUPAC name 5-but-2-enyl-5-ethyl-1,3-diazinane-2,4,6-trione
CAS Number	1952-67-6  Y
PubChem CID	5364821
ChemSpider	4516954  Y
UNII	SXW2HL5JU7
CompTox Dashboard (EPA)	DTXSID90905095
ECHA InfoCard	100.016.162
Chemical and physical data
Formula	C10H14N2O3
Molar mass	210.233 g·mol−1
3D model (JSmol)	Interactive image
SMILES O=C1NC(=O)NC(=O)C1(CC)C/C=C/C
InChI InChI=1S/C10H14N2O3/c1-3-5-6-10(4-2)7(13)11-9(15)12-8(10)14/h3,5H,4,6H2,1-2H3,(H2,11,12,13,14,15)/b5-3+ Y Key:KNMOHCLEINXVBG-HWKANZROSA-N Y
(verify)

Crotylbarbital (Mepertan, Kalipnon, Barotal), also known as crotarbital, is a barbiturate derivative developed by Eli Lilly in the 1930s. ^[1] It has sedative and hypnotic effects, ^[2] and was used for the treatment of insomnia until it was replaced by newer alternative drugs with fewer side effects and lower risk of overdose.

See also

• Barbiturate

References

1. US 2250422,Shonle HA, Doran WJ,"Alkyl-crotyl barbituric acids and their salts",issued 22 July 1941, assigned to Eli Lilly 
2. Walther T, Meyer FP, Puchta K, Walther H (June 1983). "Effect of an acute dose of crotylbarbital on reaction time and attention testing in healthy human subjects". International Journal of Clinical Pharmacology, Therapy, and Toxicology. 21 (6): 306–10. PMID   6136469.